Tuesday, 3 September 2019

Nasal Drug Delivery Market Growth and Restrain Factors Analysis By 2023

Market Scenario
Market Research Future (MRFR) has published a research report that visualizes huge increase for the Middle East & Africa (MEA) nasal drug delivery market with 8.1% CAGR (Compound Annual Growth Rate) between 2015 and 2022. In terms of cash, the market is expected to rise to US $ 1.59 bn.
Rapid development in the medical field and pharmaceutical industry is leading to the introduction of highly effective and innovative modes of drug administration systems for treating various medical conditions. Nasal drug delivery system is utilized for the treatment of local infections such as allergies, sinusitis, rhinitis, and others in the nasal course or paranasal sinuses. High prevalence of viral infections that causes blockage of the nasal cavity and respiratory disorders are inducing high demand for advanced treatment in the global market, leading to the expansion of the Middle East and Africa nasal drug delivery market. Increased availability of treatment solutions and proliferation in government initiative to provide treatment in the remote areas due to high unmet medical needs of the population in these areas are also propelling the growth of the Middle East and Africa nasal drug delivery market during the assessment period.
Some more factors that drive this market include ease of administration, growing efficacy of the route due to the development of drugs, that is absorbed easily from the nasal route and the development of advanced products. Metered dose pressurized containers are capable of delivering the precise dose. This report evaluates the market structure and features expert opinions that help readers to understand the market scenario with future growth potential. It also analyzes the competitive developments of this market. The factors that can hinder the market growth include irritation of the nasal route, low awareness and concurrent low popularity of the route, and a low dose of the drug. Due to low awareness and low popularity, few companies deliver nasal drugs. This makes the market for nasal drug delivery has oligopolistic with a few dominant players. Oligopoly gives more power to sellers.
Key Players
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi-Aventis
  • Merck & Co., Inc.
  • AptarGroup Inc.
  • Johnson & Johnson Services, Inc.
  • GlaxoSmithKline plc
  • Becton Dickson & Company
Segments:
Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.
Regional Analysis
UAE is the largest market for nasal drug delivery in entire Middle East and Africa nasal drug delivery Market closely followed by Egypt. The rest of Africa’s market is growing at a very fast rate due to huge unmet medical needs and growing popularity of nasal route.
Drivers and Restraints
The market for nasal drug delivery is growing remarkably with a consistently good CAGR due to the benefits accompanying nasal drugs.  Other driving factors include innovation of drugs which are absorbed easily from the nasal route, innovations in advanced products which allow the delivery of precise doses and also ease of administration. However, the restraints that threaten the growth of the market are irritation of the nasal route and the low dose of the drug that can be delivered as compared to other routes of administration. Other constraints include concurrent low popularity of the route which reduces economies of scale in producing these delivery devices and low awareness. According to an extensive report by Market Research Future (MRFR), the Middle East and Africa nasal drug delivery market is presumed to reach around USD 1.59 billion in 2022 surging at a CAGR of 8.1% from 2017 to 2022. The market was estimated to be worth USD 1 billion in 2015.
Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

        
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

No comments:

Post a Comment